This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Journal and News Scan

Source: Journal of Thoracic and Cardiovascular Surgery
Author(s): M Sato, F Chen, A Aoyama, T Yamada, M Ikeda, T Bando, H Date

3-D virtual bronchoscopy was used to develop two modes of virtual bronchoscopic ultrasound to assist in determining the ideal location and angle for needle insertion for TBNA. The simple method required standard computation methods, the involved method required advanced computation methods, the latter was more intuitive to use. Both methods obviated the need for EBUS for identifying puncture sites for performing TBNA, and might serve as a complement for current techniques.

Source: Radcliffe Infirmary in Oxford
Author(s): Simon Kennon

In the second session from the TAVI Round Table Discussion, the assembled panel of internationally-recognised opinion leaders discuss planning the procedure.

Designed to support the continuous education of practicing physicians, this second session shares leading opinion and addresses the following questions and key educational objectives:

Assessment: Imaging and investigations
Should trans-femoral be the default access route?
General anaesthetic or sedation; TOE or ICE?
Closure device or surgical cut down?
The panel for this session comprises:

Simon Kennon (Chair), London Chest Hospital, UK
Jonathan Byrne, King's College Hospital, London, UK
Enrico Ferrari, Cardiovascular Surgery Department, University Hospital of Lausanne, Switzerland
Carlos Ruiz, Lenox Hill Heart and Vascular Institute of New York, US
Lars Søndergaard, Rigshospitalet Copenhagen University Hospital, Denmark
Corrado Tamburino, University of Catania, Catania, Italy
Radcliffe Cardiology and Interventional Cardiology Review extend their thanks to all panel members.

Source: Interactive Journal of Cardiovascular and Thoracic Surgery
Author(s): Stefan C. Sandker, Gianclaudio Mecozzi, Azuwerus van Buiten, Massimo A. Mariani, Hendrik Buikema, and Jan G. Grandjean

The authors showed in an ex vivo model, that the adventitial dissected radial artery is less susceptible to vasoconstriction and more prone to vasorelaxation. Adventitial dissection of the radial artery graft might reduce vasospasm for arterial revascularization in CABG.

Source: European Journal of Cardio-Thoracic Surgery
Author(s): Kristian Bartnes, Stig E. Hermansen, Øystein Dahl-Eriksen, Ramez Bahar, Rolf Busund, Dag G. Sørlie, and Truls Myrmel

This long-term follow up on 290 grafted vessels did not find a disadvantage of vein grafts compared to IMA or radial artery. Native occlusion correlated with serum-cholesterol and was predicted by right coronary artery territory, patent corresponding graft, the corresponding graft being an IMA and end-to-side anastomosis.

Source: European Journal of Cardio-Thoracic Surgery
Author(s): Phil Botha, Ruth Solana, Jane Cassidy, Gareth Parry, Richard Kirk, Asif Hasan, and Massimo Griselli

The proportion of pediatric patients with mechanical circulatory support (MCS) prior to heart transplantation has increased from 27% to 51% in the recent years. These patients have a higher 30-day post-transplant mortality and suffer more neurological and respiratory sequelae. However, more transplantations were possible due to the use of MCS.

Source: Journal of Thoracic and Cardiovascular Surgery
Author(s): Umberto Benedetto,Massimiliano Codispoti

9005 patients. No cause of death or graft patency data available but RAs strongly associated with improved long-term survival in patients under 60, with survival benefit extending until 70.

Source: European Journal of Cardiothoracic Surgery
Author(s): Joel Dunning, Myura Nagendran, Ottavio R. Alfieri, Stefano Elia, A. Pieter Kappetein, Ulf Lockowandt, George E. Sarris, Phillippe H. Kolh, on behalf of the EACTS Clinical Guidelines Committee

Here is a new guideline on the surgical treatment of Atrial Fibrillation. It is a difficult area for guidelines and here we address just some of the issues involved including the energy sources, left atrial appendage, warfarin management and indications for surgery.

Source: SCTS
Author(s): NICOR

We are pleased to announce that the SCTS iData web application, designed to support shared decision making, is now available to use at Acting as a ‘window’ into National Adult Cardiac Surgery Audit (NACSA) data, the iData app allows users to place filters on CABG, AVR and MV data to gain access to a report showing aggregated analysis of every patient receiving heart surgery in the UK between April 2008 – March 2012. Reports provide a running total of procedures as you add each filter, with the option to generate a report at any time. Reports show users averages of: · In-hospital mortality · 1 Year mortality · EuroSCORE · EuroSCORE II · Post-operative length of stay Instructions · You must select an operation type (CABG, AVR or MV) on the first screen and an operation type on the second screen before applying any further filters or generating a report · Each additional variable selected will reduce the sample size on which the resultant report is based. Clinical judgement must be used to keep sample sizes as large as possible, and caution exerted when viewing results based on small samples · For Internet Explorer Users: the app only works on versions of Internet Explorer supported by Microsoft (i.e. IE10) The application will soon be available to download onto iOS devices for free from the Apple store. You can view a demo of the iOS app on YouTube here. Queries and feedback should be directed to NACSA Project Manager, Rebecca Cosgriff ( We hope that you find the iData application useful; the latest in a series of outputs from the National Adult Cardiac Surgery Audit including: · – Hospital and national level activity, trends and data quality · - Hospital and consultant level activity and in-hospital risk adjusted mortality · - what patients can expect from their heart surgeons

Source: Circulation
Author(s): Ka Sing Lawrence Wong, FRCP; Yilong Wang, MD; Xinyi Leng, PhD; Chen Mao, PhD; Jinling Tang, FFPH; Philip M.W. Bath, FRCP; Hugh S. Markus, FRCP; Philip B. Gorelick, FACP; Liping Liu, MD; Wenhua Lin, PhD; Yongjun Wang, MD

Emerging studies suggest that early administration of dual antiplatelet therapy may be better than monotherapy for prevention of early recurrent stroke and cardiovascular outcomes in acute ischemic stroke and transient ischemic attack (TIA). The authors performed a meta–analysis of randomized, controlled trials evaluating dual versus mono antiplatelet therapy for acute noncardioembolic ischemic stroke or TIA. For patients with acute noncardioembolic ischemic stroke or TIA, dual therapy was more effective than monotherapy in reducing risks of early recurrent stroke. The results of the CHANCE study are consistent with previous studies done in other parts of the world. Methods The authors assessed randomized, controlled trials investigating dual versus mono antiplatelet therapy published up to November 2012 and the CHANCE trial (Clopidogrel in High–risk patients with Acute Non–disabling Cerebrovascular Events), for efficacy and safety outcomes in adult patients with acute noncardioembolic ischemic stroke or TIA with treatment initiated within 3 days of ictus. In total, 14 studies of 9012 patients were included in the systematic review and meta–analysis. Results Dual antiplatelet therapy significantly reduced risk of stroke recurrence (risk ratio, 0.69; 95% confidence interval, 0.60–0.80; P<0.001) and the composite outcome of stroke, TIA, acute coronary syndrome, and all death (risk ratio, 0.71; 95% confidence interval, 0.63–0.81; P<0.001) when compared with monotherapy, and nonsignificantly increased risk of major bleeding (risk ratio, 1.35; 95% confidence interval, 0.70–2.59, P=0.37). Analyses restricted to the CHANCE Trial or the 7 double–blind randomized, controlled trials showed similar results.

Source: The Lancet Oncology
Author(s): O Raaschou-Nielson and others

The authors surveyed the effects of particulate air pollution on the development of lung cancer and the adenocarcinoma subtype in 17 European cohorts totalling over 300,000 members and over 4 million person-years at risk.  Over 2,000 lung cancers were diagnosed during the follow-up period.  Particulate pollution was associated with a 20% increase in the risk of lung cancer and a 50% increase in the risk of adenocarcinoma.